HCC is a benign, idiopathic phenomenon, appears transiently in new borns, on days 2-5 of life. To date, few reports of this condition have appeared in the literature, due to its transience. It is seen most often in healthy neonates. Occasional reports are there with prematurity, low birth weight, hypoxia, and systemic use of prostaglandin E1 or intracranial injury. [2] Our case is the second one in literature where HCC occurs in neonate suffering from meningitis. [3] HCC can also be associated with congenital or acquired lesions of hypothalamus, brain stem, cervical sympathetic nervous system, or of the second and third spinal cord thoracic segments. [4] It is thought that hypothalamic immaturity causes temporary imbalance in the tone of cutaneous blood vessels leading to this type of phenomenon. [5] Therefore, erythematous areas result due to unregulated regional capillary vasodilatation and pale areas results from regional vasoconstriction. The differential diagnosis includes port-wine stain and nascent hemangioma of infancy. [6] The transient nature of HCC helps to differentiate it from these other conditions.
In conclusion, all physicians should recognize its characteristic appearance to avoid unnecessary investigations and medications to treat it.
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Sir, Harlequin color change (HCC) represents a idiopathic phenomenon where there is a sudden change in skin color, often with a distinct edge along midline of the body, dividing neonate body skin into a pale half and a plethoric half. Occasionally, the line of demarcation may be incomplete, sparing the face and genitalia.
Changing the infant's position may reverse the pattern. [1] It usually resolves within minutes without any treatment. Repeated episodes may also occur. We here present a neonate suffering from meningitis with HCC.
A preterm, 33 weeks gestation male neonate was born by emergency cesarean section for prolonged rupture of membrane (>48 h) and nonprogression of labor. After birth, he had developed respiratory distress (Downe score-5) and was put on intravenous fluid, oxygen, and prophylactic antibiotic with ampicillin and gentamycin. At day 3 of life, he developed features of sepsis. We had changed the antibiotic. Despite that on day 4, a focal clonic seizure was occurred. It was followed by a transient erythematous rash on the left side of the trunk. The right side was relatively paler and rest of the body color was normal [ Figure 1 ]. The rash rapidly vanished within 2 min from its appearance. Later, the baby was diagnosed as a case of meningitis. Blood culture shows the growth of Klebsiella. We had treated accordingly and discharged the baby after 24 days of life. Sir, Early leprosy relapse is probably due to inadequate treatment and late relapse due to bacillary persistence or re-infection. Relapse of leprosy is an important quality of service indicators in assessing the long-term efficacy of chemotherapy, i.e., multi-drug therapy (MDT). Relapse in leprosy is compounded by irregular treatment, particularly in chronic disease. The predisposing factors for relapse include the presence of persister Bacilli, monotherapy (dapsone), inadequate or irregular therapy, the presence of multiple skin lesions and/or thickened nerves, etc. [1] After introduction of MDT for the control of leprosy, since, then, there has been a significant change in the leprosy scenario both at the global and national level, and the active case load came down drastically. Relapse rates in paucibacillary (PB) (0.65-3.0%) and multibacillary (MB) leprosy (0.02-0.8%) were estimated by various studies. [2] Reports from all over the world regarding effectiveness of MDT in MB and PB are very encouraging. However, some relapse may be and are occurring through small scale compared to the vast majority it benefits. Such relapse cases should be kept under surveillance. A 13-year-old male child was first diagnosed with PB leprosy in the year 2010. He has taken six pulses of MDT irregularly from the nearest primary health center and declared as release from treatment before reporting to our Institute.
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In July 2015, after 5 years of completion of treatment (MDT), he has noticed new fresh hypo pigmented well defined patches with loss of sensation appeared over hand, leg, face and back since 3 and half months [ Figures 1-3 
